Founded in 2013, Shenzhen Xin Vision Technology Co., Ltd. (also known as Shenzhen Xin shi jiao) has established itself as a premier wholesale Network Video Recorder manufacturer and global leader in security technology. With over 15 years of deep industry expertise, we have transitioned from traditional analog systems to cutting-edge AI-integrated digital network solutions. Our mission is to democratize high-end security, ensuring that life and property safety are protected through continuous innovation.
Our engineers work tirelessly to overcome technical hurdles, developing coaxial high-definition cameras and robust NVR systems that resist hacker attacks and ensure absolute data integrity. Today, our products are ubiquitous in government, transportation, medical, and public security sectors worldwide.
The surveillance landscape is shifting from simple recording to "Proactive Intelligence." Modern Network Video Recorders (NVRs) are no longer just storage boxes; they are the brains of the security ecosystem. The integration of H.265+ Compression Technology has revolutionized wholesale procurement by reducing storage costs by up to 50% while maintaining 4K clarity. As a leading manufacturer, we are now integrating Edge AI directly into our NVR chipsets to enable real-time facial recognition and behavioral analytics without the need for expensive cloud servers.
Wholesale buyers today demand more than just technical specs. Key procurement trends include:
Our supply chain is optimized for international distribution, ensuring rapid fulfillment of bulk wholesale orders to Europe, North America, and Southeast Asia.
We provide deep customization, from hardware PCBA design to Xmeye-based software white-labeling, tailored to your brand's specific needs.
All products undergo rigorous CE, FCC, and RoHS testing. We prioritize environmental sustainability with our solar-powered product lines.
We provide comprehensive solutions across diverse verticals:
Our production lines utilize automated SMT placement and rigorous 48-hour burn-in testing to ensure a defect rate below 0.3%. Looking forward, our R&D roadmap focuses on:
Psennikow